© 2023 Moderna, Inc. All rights reserved. © 2023 Moderna, Inc. All rights reserved. Business Review Stéphane Bancel, CEO © 2023 Moderna, Inc. All rights reserved. COVID product (Spikevax) sales Increasing Spikevax share in the current season1 Resizing manufacturing footprint to accelerate gross margin expansion toward longer-term target of 75-80% 4 © 2023 Moderna, Inc. All rights reserved. Commercial Market Arpa Garay, CCO Looking Forward Stéphane Bancel, CEO 3Q23 Spikevax sales of $1.8B; updating sales out ...

Moderna, Inc. (NASDAQ:MRNA) R&D Day and Business Updates September 13, 2023 1:00 PM ET Company Participants Stephane Bancel - CEO Stephen Hoge - President Jackie Miller - SVP, Therapeutic Area Head, Infectious Diseases Darin Edwards - Executive Director, COVID Vaccines Program Leader Raffael Nachbagauer - Program Leader for Influenza Vaccines Arpa Garay - Chief Commercial Officer Kyle Holen - Head of Development, Oncology and Therapeutics Michelle Nguyen - Director of Marketing James Mock - CFO Conference C ...

Moderna, Inc. (NASDAQ:MRNA) Morgan Stanley 21st Annual Global Healthcare Conference September 12, 2023 12:15 PM ET Company Participants Stephane Bancel - CEO Conference Call Participants Terence Flynn - Morgan Stanley Terence Flynn Great. Well, good afternoon, everybody. Thanks for joining us. I???m Terence Flynn, the U.S. biopharm analyst at Morgan Stanley. We???re very pleased to be hosting Moderna this afternoon. We have Stephane Bancel, who is the Company???s CEO, Stephane, thanks so much for being here ...

Moderna, Inc. (NASDAQ:MRNA) Q2 2023 Results Earnings Conference Call August 3, 2023 8:00 AM ET Company Participants Lavina Talukdar - Head, Investor Relations St??phane Bancel - Chief Executive Officer Stephen Hoge - President Arpa Garay - Chief Commercial Officer Jamey Mock - Chief Financial Officer Conference Call Participants Salveen Richter - Goldman Sachs Tyler Van Buren - TD Cowen Gena Wang - Barclays Capital Dina Elmonshed - Jefferies Luca Issi - RBC Capital Markets Edward Tenthoff - Piper Sandler E ...

Second Quarter 2023 Financial Results moderr l Financial figures in this presentation as of, and for the quarterly periods ended, June 30, 2023, and June 30, 2022, are unaudited. 2 2Q23 earnings call agenda R&D/Clinical Programs Stephen Hoge, M.D., President Financials Jamey Mock, CFO 3 2Q23 financial highlights Net income (loss): $(1.4) billion Reinvest in the business • $0.2 billion capital expenditures Return capital to shareholders 2Q 2023 Update| Business Review • Submitted updated COVID-19 vaccine to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _ to _ Commission File Number: 001-38753 Moderna, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 81-3467528 (State or Other Jurisdiction of ...

Moderna, Inc. (NASDAQ:MRNA) Goldman Sachs 44th Annual Global Healthcare Conference June 14, 2023 7:40 PM ET Company Participants Jamey Mock - CFO Lavina Talukdar - Head of IR Conference Call Participants Salveen Richter - Goldman Sachs Salveen Richter Great. Good afternoon, everyone. Thanks so much for joining us. I am Salveen Richter, Biotechnology Analyst at Goldman Sachs. Really pleased to have the team from Moderna here today. So we have Jamey Mock, CFO; and Lavina Talukdar, Head of IR. So with that, m ...

Moderna, Inc. (NASDAQ:MRNA) Jefferies Global Healthcare Conference June 8, 2023 10:30 AM ET Company Participants Stephen Hoge - President Conference Call Participants Michael Yee - Jefferies Michael Yee Well, thank you, everyone, for joining us on our next session up here. I think our next guest needs no introduction. He's the President of Moderna, Stephen Hoge. It's good to be here with you. We just came away from ASCO. So, there's some cancer topics to discuss. I'm sure the audience would love to start of ...

Moderna, Inc. (NASDAQ:MRNA) ASCO Investor Event Conference Call June 5, 2023 7:00 PM ET Company Participants Lavina Talukdar - Senior Vice President and Head of Investor Relations Stephen Hoge - President Kyle Holen - Senior Vice President and Head of Development, Therapeutics and Oncology Conference Call Participants Edward Tenthoff - Piper Sandler & Co. Tyler Van Buren - Cowen and Company, LLC Mani Foroohar - SVB Securities LLC Luca Issi - RBC Capital Markets Gena Wang - Barclays Bank plc Michael Yee - Je ...

Moderna, Inc. (NASDAQ:MRNA) Q1 2023 Results Conference Call May 4, 2023 8:00 AM ET Company Participants Lavina Talukdar - Head, Investor Relations Stephane Bancel - Chief Executive Officer Stephen Hoge - President Arpa Garay - Chief Commercial Officer Jamey Mock - Chief Financial Officer Conference Call Participants Gena Wang - Barclays Salveen Richter - Goldman Sachs Tara Bancroft - with TD Cowen Michael Yee - Jefferies Terence Flynn - Morgan Stanley Jessica Fye - JPMorgan Ellie Merle - UBS Luca Issi - RBC ...